ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Fred Hutchinson Director Lee Hartwell To Retire Next Year; Board Begins Search

July 3, 2009

NIH Plans Consensus Conference On Ovarian Cancer April 5-7

January 28, 1994

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

January 17, 2014

In Brief: Top Priority: Keep Rauscher; Pay Raise Bill No Moving; Miller, Holland Head AACR, ASCO

May 21, 1976

NCI Requests $5.69 Billion To Seize Opportunities In FY03.

January 11, 2002

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992